Illumina, Inc. (ILMN) Launches New Reagent Kits for the MiSeq® System
8/19/2013 9:25:57 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced the availability of its newest reagent kits for the MiSeq, the industry’s most accurate and easiest-to-use benchtop sequencer. The improved chemistry doubles sequencing output to 15 gigabases (Gb) by increasing the number of sequencing reads (up to 25 million reads) and overall read length (up to 2x300 base pairs). These innovations enable researchers to perform new applications including exome sequencing on the MiSeq.
Help employers find you! Check out all the jobs and post your resume.
comments powered by